NSCLC subtype prediction using cytologic fluid specimens from needle aspiration biopsies

Arthur Cho, Jin Hur, Yoo Jin Hong, Hye Jeong Lee, Youngjin Kim, Hee Yeong Kim, Ji Won Lee, Hyo Sup Shim, Byoung Wook Choi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

This study evaluated the diagnostic usefulness of tumor marker concentrations in cytologic fluids (CF) for subtyping non-small cell lung cancer (NSCLC) and assessed the relationship between fluorine-18- fluorodeoxyglucose (18F-FDG) uptake with serum and CF tumor marker levels. This prospective study included 88 patients diagnosed with adenocarcinoma or squamous cell carcinoma (SCC). Cytokeratin-19 fragment (CYFRA 21-1), carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCCA) concentrations in the CF samples were correlated with serum tumor marker concentrations, 18F-FDG uptake, and NSCLC subtype. Fifty-eight patients were diagnosed with adenocarcinoma. Multivariate analysis revealed higher CF and serum SCCA levels; smoking status predicted SCC from adenocarcinoma. CF SCCA showed the highest accuracy (83%) in distinguishing between SCC and adenocarcinoma. CF samples obtained during routine needle aspiration biopsy procedure contain tumor marker levels sufficient to distinguish between SCC and adenocarcinoma; CF SCCA had the highest diagnostic accuracy.

Original languageEnglish
Pages (from-to)309-316
Number of pages8
JournalAmerican Journal of Clinical Pathology
Volume139
Issue number3
DOIs
Publication statusPublished - 2013 Mar 1

Fingerprint

Needle Biopsy
Non-Small Cell Lung Carcinoma
Tumor Biomarkers
Adenocarcinoma
Squamous Cell Carcinoma
Fluorodeoxyglucose F18
Keratin-19
Carcinoembryonic Antigen
Serum
Multivariate Analysis
Biomarkers
Smoking
Prospective Studies
squamous cell carcinoma-related antigen

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

Cite this

Cho, Arthur ; Hur, Jin ; Hong, Yoo Jin ; Lee, Hye Jeong ; Kim, Youngjin ; Kim, Hee Yeong ; Lee, Ji Won ; Shim, Hyo Sup ; Choi, Byoung Wook. / NSCLC subtype prediction using cytologic fluid specimens from needle aspiration biopsies. In: American Journal of Clinical Pathology. 2013 ; Vol. 139, No. 3. pp. 309-316.
@article{ea4670171da44cfba9d85b0cd554b12e,
title = "NSCLC subtype prediction using cytologic fluid specimens from needle aspiration biopsies",
abstract = "This study evaluated the diagnostic usefulness of tumor marker concentrations in cytologic fluids (CF) for subtyping non-small cell lung cancer (NSCLC) and assessed the relationship between fluorine-18- fluorodeoxyglucose (18F-FDG) uptake with serum and CF tumor marker levels. This prospective study included 88 patients diagnosed with adenocarcinoma or squamous cell carcinoma (SCC). Cytokeratin-19 fragment (CYFRA 21-1), carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCCA) concentrations in the CF samples were correlated with serum tumor marker concentrations, 18F-FDG uptake, and NSCLC subtype. Fifty-eight patients were diagnosed with adenocarcinoma. Multivariate analysis revealed higher CF and serum SCCA levels; smoking status predicted SCC from adenocarcinoma. CF SCCA showed the highest accuracy (83{\%}) in distinguishing between SCC and adenocarcinoma. CF samples obtained during routine needle aspiration biopsy procedure contain tumor marker levels sufficient to distinguish between SCC and adenocarcinoma; CF SCCA had the highest diagnostic accuracy.",
author = "Arthur Cho and Jin Hur and Hong, {Yoo Jin} and Lee, {Hye Jeong} and Youngjin Kim and Kim, {Hee Yeong} and Lee, {Ji Won} and Shim, {Hyo Sup} and Choi, {Byoung Wook}",
year = "2013",
month = "3",
day = "1",
doi = "10.1309/AJCPYOJYG56UNBSZ",
language = "English",
volume = "139",
pages = "309--316",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "3",

}

NSCLC subtype prediction using cytologic fluid specimens from needle aspiration biopsies. / Cho, Arthur; Hur, Jin; Hong, Yoo Jin; Lee, Hye Jeong; Kim, Youngjin; Kim, Hee Yeong; Lee, Ji Won; Shim, Hyo Sup; Choi, Byoung Wook.

In: American Journal of Clinical Pathology, Vol. 139, No. 3, 01.03.2013, p. 309-316.

Research output: Contribution to journalArticle

TY - JOUR

T1 - NSCLC subtype prediction using cytologic fluid specimens from needle aspiration biopsies

AU - Cho, Arthur

AU - Hur, Jin

AU - Hong, Yoo Jin

AU - Lee, Hye Jeong

AU - Kim, Youngjin

AU - Kim, Hee Yeong

AU - Lee, Ji Won

AU - Shim, Hyo Sup

AU - Choi, Byoung Wook

PY - 2013/3/1

Y1 - 2013/3/1

N2 - This study evaluated the diagnostic usefulness of tumor marker concentrations in cytologic fluids (CF) for subtyping non-small cell lung cancer (NSCLC) and assessed the relationship between fluorine-18- fluorodeoxyglucose (18F-FDG) uptake with serum and CF tumor marker levels. This prospective study included 88 patients diagnosed with adenocarcinoma or squamous cell carcinoma (SCC). Cytokeratin-19 fragment (CYFRA 21-1), carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCCA) concentrations in the CF samples were correlated with serum tumor marker concentrations, 18F-FDG uptake, and NSCLC subtype. Fifty-eight patients were diagnosed with adenocarcinoma. Multivariate analysis revealed higher CF and serum SCCA levels; smoking status predicted SCC from adenocarcinoma. CF SCCA showed the highest accuracy (83%) in distinguishing between SCC and adenocarcinoma. CF samples obtained during routine needle aspiration biopsy procedure contain tumor marker levels sufficient to distinguish between SCC and adenocarcinoma; CF SCCA had the highest diagnostic accuracy.

AB - This study evaluated the diagnostic usefulness of tumor marker concentrations in cytologic fluids (CF) for subtyping non-small cell lung cancer (NSCLC) and assessed the relationship between fluorine-18- fluorodeoxyglucose (18F-FDG) uptake with serum and CF tumor marker levels. This prospective study included 88 patients diagnosed with adenocarcinoma or squamous cell carcinoma (SCC). Cytokeratin-19 fragment (CYFRA 21-1), carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCCA) concentrations in the CF samples were correlated with serum tumor marker concentrations, 18F-FDG uptake, and NSCLC subtype. Fifty-eight patients were diagnosed with adenocarcinoma. Multivariate analysis revealed higher CF and serum SCCA levels; smoking status predicted SCC from adenocarcinoma. CF SCCA showed the highest accuracy (83%) in distinguishing between SCC and adenocarcinoma. CF samples obtained during routine needle aspiration biopsy procedure contain tumor marker levels sufficient to distinguish between SCC and adenocarcinoma; CF SCCA had the highest diagnostic accuracy.

UR - http://www.scopus.com/inward/record.url?scp=84875883172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875883172&partnerID=8YFLogxK

U2 - 10.1309/AJCPYOJYG56UNBSZ

DO - 10.1309/AJCPYOJYG56UNBSZ

M3 - Article

C2 - 23429366

AN - SCOPUS:84875883172

VL - 139

SP - 309

EP - 316

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 3

ER -